scholarly article | Q13442814 |
P2093 | author name string | G T Macfarlane | |
J H Cummings | |||
W J Branch | |||
E W Pomare | |||
C P Naylor | |||
P2860 | cites work | Direct measurement of hepatic blood flow in surgical patients: with related observations on hepatic flow dynamics in experimental animals | Q79072321 |
Respiratory hydrogen and methane as affected by consumption of gas-forming foods | Q33480188 | ||
Short chain fatty acid absorption by the human large intestine | Q34474870 | ||
Carbohydrate fermentation in the human colon and its relation to acetate concentrations in venous blood | Q34626788 | ||
Digestion of the polysaccharides of some cereal foods in the human small intestine | Q38596320 | ||
Sites of organic acid production and absorption in gastrointestinal tract of the pig | Q40310785 | ||
Short chain fatty acids in the human colon | Q40318098 | ||
Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man | Q41646819 | ||
Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device | Q41981421 | ||
Short-chain fatty acids in the normal human feces. | Q42256509 | ||
VFA production in the pig large intestine | Q44034265 | ||
The effect of meat protein and dietary fiber on colonic function and metabolism II. Bacterial metabolites in feces and urine | Q45043396 | ||
Effect of purified cellulose, pectin, and a low-residue diet on fecal volatile fatty acids, transit time, and fecal weight in humans | Q47296392 | ||
Passage of carbohydrate into the colon. Direct measurements in humans. | Q51645874 | ||
Partition and absorption of valatile fatty acids in the alimentary canal of the rat | Q51671868 | ||
Absorption of electrolytes and volatile fatty acids in the hind-gut of the rabbit. Circadian rhythm of hind-gut electrolytes and plasma aldosterone. | Q54594887 | ||
Digestion of polysaccharides of potato in the small intestine of man. | Q55061057 | ||
VFA metabolism in the pig | Q67429178 | ||
Protein degradation by human intestinal bacteria | Q68929525 | ||
Starch utilization by the human large intestinal microflora | Q68963433 | ||
Parameters in 7-alpha-dehydroxylation of bile acids by anaerobic lactobacilli | Q69845380 | ||
Effects of wheat bran and porridge oats on hepatic portal venous volatile fatty acids in the pig | Q70108493 | ||
Digestion of the carbohydrates of banana (Musa paradisiaca sapientum) in the human small intestine | Q70143385 | ||
Influence of Dietary Fiber on Fecal Excretion of Volatile Fatty Acids by Human Adults | Q70154325 | ||
Volatile fatty acids in human peripheral and portal blood: Quantitative determination by vacuum distillation and gas chromatography | Q70757540 | ||
Hydrogen and methane production in man | Q70931020 | ||
In vivo dialysis of faeces as a method of stool analysis. IV. The organic anion component | Q71257146 | ||
Composition of fecal water. Comparison of "in vitro" dialysis with ultrafiltration | Q71325133 | ||
Absorption of short-chain fatty acids by the colon | Q71500547 | ||
Calorie conversion factors. An experimental reassessment of the factors used in the calculation of the energy value of human diets | Q71525607 | ||
Dietary fibre | Q72901650 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | fatty acid | Q61476 |
P304 | page(s) | 1221-1227 | |
P577 | publication date | 1987-10-01 | |
P1433 | published in | Gut | Q5621669 |
P1476 | title | Short chain fatty acids in human large intestine, portal, hepatic and venous blood | |
P478 | volume | 28 |
Q99711009 | 1-Kestose supplementation mitigates the progressive deterioration of glucose metabolism in type 2 diabetes OLETF rats |
Q37980065 | 1H NMR-based metabonomic applications to decipher gut microbial metabolic influence on mammalian health |
Q87299716 | 22nd European Congress on Obesity (ECO2015), Prague, Czech Republic, May 6-9, 2015: Abstracts |
Q27349443 | A Salmonella small non-coding RNA facilitates bacterial invasion and intracellular replication by modulating the expression of virulence factors |
Q36092593 | A Single-Batch Fermentation System to Simulate Human Colonic Microbiota for High-Throughput Evaluation of Prebiotics |
Q44520835 | A cereal-based evening meal rich in indigestible carbohydrates increases plasma butyrate the next morning |
Q28817237 | A fibrolytic potential in the human ileum mucosal microbiota revealed by functional metagenomic |
Q43108368 | A human volunteer study to assess the impact of confectionery sweeteners on the gut microbiota composition |
Q47228407 | A look at the smelly side of physiology: transport of short chain fatty acids. |
Q36081100 | A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression |
Q35961915 | A search for synbiotics: effects of enzymatically modified arabinoxylan and Butyrivibrio fibrisolvens on short-chain fatty acids in the cecum content and plasma of rats |
Q92134251 | A study protocol for a randomised crossover study evaluating the effect of diets differing in carbohydrate quality on ileal content and appetite regulation in healthy humans |
Q58766089 | Absorption of Saponins by Coexisting Polysaccharides Alleviates Gut Microbial Dysbiosis with Dextran Sulfate Sodium-Induced Colitis in Model Mice |
Q34208819 | Absorption of the indigestible disaccharide, β-1,4-mannobiose, from coconut by the rat portal vein |
Q89896507 | Acetate and Butyrate Improve β-cell Metabolism and Mitochondrial Respiration under Oxidative Stress |
Q33555165 | Acetate and formate stress: opposite responses in the proteome of Escherichia coli |
Q34095383 | Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine |
Q41860134 | Acetylation of the Entamoeba histone H4 N-terminal domain is influenced by short-chain fatty acids that enter trophozoites in a pH-dependent manner |
Q40408331 | Acid sphingomyelinase is induced by butyrate but does not initiate the anticancer effect of butyrate in HT29 and HepG2 cells |
Q33900360 | Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids |
Q35832535 | Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization |
Q41210530 | Activation of Short and Long Chain Fatty Acid Sensing Machinery in the Ileum Lowers Glucose Production in Vivo |
Q43264378 | Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha |
Q38542707 | Adaptation and tolerance of bacteria against acetic acid |
Q43296243 | Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects |
Q44942837 | Additional prognostic factors in right colon cancer staging. |
Q57759719 | Alternative method for gas chromatography-mass spectrometry analysis of short-chain fatty acids in faecal samples |
Q34392294 | Alternative pathways for hydrogen disposal during fermentation in the human colon |
Q36411671 | An Na(+)-independent short-chain fatty acid transporter contributes to intracellular pH regulation in murine colonocytes |
Q49943064 | An Oxidative Central Metabolism Enables Salmonella to Utilize Microbiota-Derived Succinate. |
Q39804998 | An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties |
Q54656339 | Anaerobes and their fermentation products in faeces of patients with familial adenomatous polyposis before and after subtotal colectomy and ileorectal anastomosis. |
Q34064840 | Analysis of the expression, secretion and translocation of the Salmonella enterica type III secretion system effector SteA |
Q34085452 | Anisotropic nutrient transport in three-dimensional single species bacterial biofilms. |
Q35124775 | Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms |
Q46548619 | Anti-inflammatory properties of heat shock protein 70 and butyrate on Salmonella-induced interleukin-8 secretion in enterocyte-like Caco-2 cells |
Q36597847 | Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota |
Q34687944 | Anticarcinogenic effects of diet-related apoptosis in the colorectal mucosa. |
Q50131456 | Antimutagenic properties of probiotic bacteria and of organic acids |
Q41110587 | Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors |
Q38191918 | Approaches that ascertain the role of dietary compounds in colonic cancer cells |
Q33918713 | Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis? |
Q40737287 | Assessing digestibility of Hadza tubers using a dynamic in-vitro model |
Q28254504 | Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations |
Q91984505 | Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors |
Q89496925 | Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids |
Q72824155 | Atypical forms of inflammatory bowel disease |
Q38563963 | Availability of calcium for absorption in the small intestine and colon from diets containing available and unavailable carbohydrates: an in vitro assessment |
Q36377654 | BacArena: Individual-based metabolic modeling of heterogeneous microbes in complex communities |
Q37884523 | Bacterial biofilms associated with food particles in the human large bowel. |
Q91950652 | Bacterial fecal microbiota is only minimally affected by a standardized weight loss plan in obese cats |
Q39553474 | Bacterial monocultures, propionate, butyrate and H2O2 modulate the expression, secretion and structure of the fasting-induced adipose factor in gut epithelial cell lines |
Q43357473 | Bacterial population dynamics and faecal short-chain fatty acid (SCFA) concentrations in healthy humans |
Q34061152 | Bacterial strains from human feces that reduce CO2 to acetic acid. |
Q41147850 | Beef, Chicken, and Soy Proteins in Diets Induce Different Gut Microbiota and Metabolites in Rats |
Q91841916 | Beneficial and detrimental effects of processed dietary fibers on intestinal and liver health: health benefits of refined dietary fibers need to be redefined! |
Q38817405 | Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis |
Q35609234 | Beta glucan: health benefits in obesity and metabolic syndrome. |
Q64071761 | Beyond Gut Instinct: Metabolic Short-Chain Fatty Acids Moderate the Pathogenesis of Alphaherpesviruses |
Q40081529 | Beyond gut feelings: how the gut microbiota regulates blood pressure. |
Q49564644 | Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology |
Q34592569 | Biochemical and kinetic characterization of the recombinant ADP-forming acetyl coenzyme A synthetase from the amitochondriate protozoan Entamoeba histolytica |
Q51028237 | Biosynthesis of butenoic acid through fatty acid biosynthesis pathway in Escherichia coli. |
Q38955157 | Black-Box Gastrointestinal Tract-Needs and Prospects of Gaining Insights of Fate of Fat, Protein, and Starch in Case of Exocrine Pancreatic Insufficiency by Using Fistulated Pigs. |
Q53705819 | Blueberry Supplementation Influences the Gut Microbiota, Inflammation, and Insulin Resistance in High-Fat-Diet-Fed Rats. |
Q44509324 | Body composition and amino acid concentrations of select birds and mammals consumed by cats in northern and central California |
Q27014531 | Brain-gut microbiome interactions and functional bowel disorders |
Q90601591 | Branched Short-Chain Fatty Acid Isovaleric Acid Causes Colonic Smooth Muscle Relaxation via cAMP/PKA Pathway |
Q42115138 | Branched short-chain fatty acids modulate glucose and lipid metabolism in primary adipocytes. |
Q85166820 | Brewer's yeast cell wall affects microbiota composition and decreases Bacteroides fragilis populations in an anaerobic gut intestinal model |
Q41892710 | Broad substrate specificity of phosphotransbutyrylase from Listeria monocytogenes: A potential participant in an alternative pathway for provision of acyl CoA precursors for fatty acid biosynthesis |
Q47142681 | Butyrate Conditions Human Dendritic Cells to Prime Type 1 Regulatory T Cells via both Histone Deacetylase Inhibition and G Protein-Coupled Receptor 109A Signaling |
Q60959907 | Butyrate Produced by Commensal Bacteria Down-Regulates () Expression a Dual Mechanism in Human Intestinal Epithelial Cells |
Q40071271 | Butyrate Supplementation at High Concentrations Alters Enteric Bacterial Communities and Reduces Intestinal Inflammation in Mice Infected with Citrobacter rodentium |
Q38731993 | Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a]pyrene via its histone deacetylase activity in colon epithelial cell models. |
Q37786181 | Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? |
Q44685492 | Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells |
Q28730663 | Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms |
Q41011016 | Butyrate and the colonocyte. Implications for neoplasia |
Q40893919 | Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression |
Q41952733 | Butyrate attenuates lipolysis in adipocytes co-cultured with macrophages through non-prostaglandin E2-mediated and prostaglandin E2-mediated pathways. |
Q55315602 | Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases. |
Q39411710 | Butyrate enhancement of inteleukin-1β production via activation of oxidative stress pathways in lipopolysaccharide-stimulated THP-1 cells |
Q47640046 | Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism. |
Q35143428 | Butyrate induced changes in Wnt-signaling specific gene expression in colorectal cancer cells |
Q40956054 | Butyrate inhibits and Escherichia coli-derived mitogen(s) stimulate DNA synthesis in human hepatocytes in vitro |
Q89950234 | Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI-mediated signaling |
Q36157436 | Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells |
Q73814773 | Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cells |
Q44671236 | Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources |
Q43261028 | Butyrate mediates nucleotide-binding and oligomerisation domain (NOD) 2-dependent mucosal immune responses against peptidoglycan |
Q42489228 | Butyrate modulates TGF-beta1 generation and function: potential renal benefit for Acacia(sen) SUPERGUM (gum arabic)? |
Q34378430 | Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis |
Q38317128 | Butyrate specifically down-regulates salmonella pathogenicity island 1 gene expression. |
Q43748127 | Butyrate stimulates ApoA-IV-containing lipoprotein secretion in differentiated Caco-2 cells: role in cholesterol efflux |
Q43980803 | Butyrate strongly inhibits in vitro stimulated release of cytokines in blood. |
Q33346196 | Butyrate transcriptionally enhances peptide transporter PepT1 expression and activity |
Q37602088 | Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency |
Q64064603 | Butyrate, a metabolite of intestinal bacteria, enhances sleep |
Q40304006 | Butyrate-induced collagen biosynthesis in cultured fibroblasts is independent on alpha2beta1 integrin signalling and undergoes through IGF-I receptor cascade. |
Q37498973 | Butyrate-induced colonic hypersensitivity is mediated by mitogen-activated protein kinase activation in rat dorsal root ganglia |
Q37054060 | CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells |
Q26799062 | CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer |
Q33564151 | Caecal pH is a biomarker of excessive colonic fermentation |
Q43844053 | Cell type- and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate |
Q41584110 | Cell-Surface and Nuclear Receptors in the Colon as Targets for Bacterial Metabolites and Its Relevance to Colon Health |
Q92704716 | Change of intestinal microbiota in cerebral ischemic stroke patients |
Q89697273 | Changes in Plasma Short-Chain Fatty Acid Levels after Dietary Weight Loss Among Overweight and Obese Adults over 50 Weeks |
Q91933746 | Changes in meta-transcriptome of rumen epimural microbial community and liver transcriptome in young calves with feed induced acidosis |
Q82812159 | Changes induced in colonocytes by extensive intestinal resection in rats |
Q34544124 | Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer |
Q39517916 | Characterization of Vibrio cholerae O1 El tor galU and galE mutants: influence on lipopolysaccharide structure, colonization, and biofilm formation |
Q45942731 | Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults. |
Q37182191 | Characterization of the expression of Salmonella Type III secretion system factor PrgI, SipA, SipB, SopE2, SpaO, and SptP in cultures and in mice |
Q92155483 | Characterizing the Composition of the Pediatric Gut Microbiome: A Systematic Review |
Q34706027 | Chemopreventive potential of synergy1 and soybean in reducing azoxymethane-induced aberrant crypt foci in fisher 344 male rats |
Q48386487 | Chicory increases acetate turnover, but not propionate and butyrate peripheral turnovers in rats |
Q37096490 | Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug. |
Q35906622 | Chronically Elevated Levels of Short-Chain Fatty Acids Induce T Cell-Mediated Ureteritis and Hydronephrosis. |
Q90197702 | Citrobacter rodentium-host-microbiota interactions: immunity, bioenergetics and metabolism |
Q39538301 | Cl(-) secretion in colonic epithelial cells induced by the vibrio parahaemolyticus hemolytic toxin related to thermostable direct hemolysin |
Q61804260 | Close association between abnormal expressed enzymes of energy metabolism and diarrhea-predominant irritable bowel syndrome |
Q35685860 | Co-utilization of polymerized carbon sources by Bacteroides ovatus grown in a two-stage continuous culture system |
Q96294263 | Colon-delivered short-chain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlled trial |
Q34394089 | Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer |
Q72569101 | Colonic fermentation: metabolic and clinical implications |
Q42043689 | Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial. |
Q34407486 | Colonic mucin synthesis is increased by sodium butyrate |
Q42526475 | Colonic production of butyrate in patients with previous colonic cancer during long-term treatment with dietary fibre (Plantago ovata seeds). |
Q42181428 | Colonic responses to enteral tube feeding |
Q34438109 | Colonic sulfide in pathogenesis and treatment of ulcerative colitis |
Q34667352 | Colorectal carcinogenesis--update and perspectives. |
Q37091832 | Colorectal carcinogenesis: a cellular response to sustained risk environment. |
Q44925391 | Combination of polydextrose and lactitol affects microbial ecosystem and immune responses in rat gastrointestinal tract |
Q89510979 | Combined Soluble Fiber-Mediated Intestinal Microbiota Improve Insulin Sensitivity of Obese Mice |
Q30277859 | Commensal 'trail of bread crumbs' provide pathogens with a map to the intestinal landscape |
Q33578547 | Commensal bacteria at the interface of host metabolism and the immune system |
Q38713387 | Commensal gut bacteria modulate phosphorylation-dependent PPARγ transcriptional activity in human intestinal epithelial cells. |
Q92179021 | Comparative prebiotic activity of mixtures of cereal grain polysaccharides |
Q34486592 | Comparison of diarrhea induced by ingestion of fructooligosaccharide Idolax and disaccharide lactulose: role of osmolarity versus fermentation of malabsorbed carbohydrate |
Q44631063 | Comparison of fermentation reactions in different regions of the human colon |
Q90566304 | Compartmentalised acyl-CoA metabolism and roles in chromatin regulation |
Q35591821 | Complexity and health functionality of plant cell wall fibers from fruits and vegetables. |
Q99365520 | Compositional and functional differences of the mucosal microbiota along the intestine of healthy individuals |
Q98771344 | Contribution of Short Chain Fatty Acids to the Growth of Pseudomonas aeruginosa in Rhinosinusitis |
Q38286591 | Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms? |
Q43955557 | Cornstarch fermentation by the colonic microbial community yields more butyrate than does cabbage fiber fermentation; cornstarch fermentation rates correlate negatively with methanogenesis |
Q46419420 | Cultured ruminal epithelial cells express a large-conductance channel permeable to chloride, bicarbonate, and acetate |
Q40457847 | Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. |
Q97523185 | Daily mycoprotein consumption for one week does not affect insulin sensitivity or glycaemic control but modulates the plasma lipidome in healthy adults: a randomised controlled trial |
Q91776552 | Decreased maternal serum acetate and impaired fetal thymic and regulatory T cell development in preeclampsia |
Q37459962 | Defining an olfactory receptor function in airway smooth muscle cells. |
Q90862879 | Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome |
Q36945067 | Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells |
Q38996373 | Di- and tripeptide transport in vertebrates: the contribution of teleost fish models |
Q36453623 | Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids |
Q89476649 | Diet and Gut Microbes Act Coordinately to Enhance Programmed Cell Death and Reduce Colorectal Cancer Risk |
Q92537172 | Diet in Parkinson's Disease: Critical Role for the Microbiome |
Q28384266 | Diet, the gut microbiome, and epigenetics |
Q64059347 | Diet-induced metabolic changes of the human gut microbiome: importance of short-chain fatty acids, methylamines and indoles |
Q36305199 | Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? |
Q36465484 | Dietary agents as histone deacetylase inhibitors |
Q50146326 | Dietary fatty acids and susceptibility to multiple sclerosis |
Q33562095 | Dietary fiber and prebiotics and the gastrointestinal microbiota |
Q96431485 | Dietary fiber metabolites regulate innate lymphoid cell responses |
Q40788686 | Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects |
Q89716237 | Dietary fiber, whole grains, and head and neck cancer prognosis: findings from a prospective cohort study |
Q40340991 | Dietary fibre-based SCFA mixtures promote both protection and repair of intestinal epithelial barrier function in a Caco-2 cell model. |
Q89579541 | Dietary flaxseed oil rich in omega-3 suppresses severity of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in rats |
Q27022777 | Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation |
Q34687504 | Dietary inulin affects the expression of intestinal enterocyte iron transporters, receptors and storage protein and alters the microbiota in the pig intestine |
Q36521178 | Dietary resistant starch dose-dependently reduces adiposity in obesity-prone and obesity-resistant male rats |
Q41605413 | Dietary resistant starch type 4-derived butyrate attenuates nuclear factor-kappa-B1 through modulation of histone H3 trimethylation at lysine 27. |
Q89910241 | Dietary α-cyclodextrin reduces atherosclerosis and modifies gut flora in apolipoprotein E-deficient mice |
Q41667058 | Differences in propionate-induced inhibition of cholesterol and triacylglycerol synthesis between human and rat hepatocytes in primary culture |
Q64071180 | Differential Responses of Colorectal Cancer Cell Lines to Strains Isolated from Healthy Donors and Colorectal Cancer Patients |
Q39756970 | Differential antineoplastic effects of butyrate in cells with and without a functioning DNA mismatch repair |
Q55309517 | Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: Antioxidant action of butyrate. |
Q33928888 | Differential expression of Salmonella type III secretion system factors InvJ, PrgJ, SipC, SipD, SopA and SopB in cultures and in mice |
Q44459071 | Differential modulation of enterocyte-like Caco-2 cells after exposure to short-chain fatty acids |
Q39383678 | Differential protein abundance of a basolateral MCT1 transporter in the human gastrointestinal tract. |
Q40321679 | Differentiation effects by the combination of spheroid formation and sodium butyrate treatment in human hepatoblastoma cell line (Hep G2): a possible cell source for hybrid artificial liver |
Q41071305 | Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses. |
Q55066554 | Digestion and physiological properties of resistant starch in the human large bowel. |
Q51606591 | Digestion rate of dietary starch affects the systemic circulation of lipid profiles and lipid metabolism-related gene expression in weaned pigs. |
Q58572799 | Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1 |
Q39922062 | Dissimilatory nitrate reduction by Propionibacterium acnes. |
Q41714891 | Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms |
Q72354025 | Diversion colitis. A prospective study |
Q53395039 | Diversion proctocolitis and response to treatment with short-chain fatty acids--a clinicopathological study in children. |
Q37832302 | Do SCFA have a role in appetite regulation? |
Q33869477 | Do probiotics have a therapeutic role in gastroenterology? |
Q36053333 | Does canine inflammatory bowel disease influence gut microbial profile and host metabolism? |
Q55394822 | Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)? |
Q42094211 | Does dietary fibre stimulate intestinal epithelial cell proliferation in germ free rats? |
Q37255922 | Does the Gut Microbiota Contribute to Obesity? Going beyond the Gut Feeling |
Q58862754 | Dose‐response effects of inulin on the faecal short‐chain fatty acids content and mineral absorption of formula‐fed infants |
Q84777846 | Drug Solubility in Luminal Fluids from Different Regions of the Small and Large Intestine of Humans |
Q38223664 | Drug release from matrix tablets: physiological parameters and the effect of food |
Q59800447 | Echinococcus granulosus Infection Results in an Increase in Eisenbergiella and Parabacteroides Genera in the Gut of Mice |
Q35839938 | Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism |
Q55079819 | Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases. |
Q89633610 | Effect of Dose and Timing of Burdock (Arctium lappa) Root Intake on Intestinal Microbiota of Mice |
Q43226261 | Effect of L-glutamine and n-butyrate on the restitution of rat colonic mucosa after acid induced injury |
Q35906455 | Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature. |
Q38864370 | Effect of growth factors, estradiol 17-β, and short chain fatty acids on the intestinal HT29-MTX cells : Growth factors and SCFAs effects on intestinal E12 cells |
Q42479946 | Effect of lactulose supplementation on growth performance, intestinal histomorphology, cecal microbial population, and short-chain fatty acid composition of broiler chickens |
Q41690847 | Effect of non-surgical periodontal treatment on short chain fatty acid levels in gingival crevicular fluid of patients with generalized aggressive periodontitis |
Q41475688 | Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation |
Q51334312 | Effect of short-chain fatty acids and acidification on the phasic and tonic motor activity of the human colon. |
Q41142770 | Effect of short-chain fatty acids on the human colonic mucosa in vitro |
Q53364284 | Effect of stoma formation on bowel care and quality of life in patients with spinal cord injury. |
Q52845338 | Effect of tomato juice consumption on the plasmatic lipid profile, hepatic HMGCR activity, and fecal short chain fatty acid content of rats. |
Q38739756 | Effect of water flow and chemical environment on microbiota growth and composition in the human colon. |
Q61816816 | Effect of β-Glucan and Black Tea in a Functional Bread on Short Chain Fatty Acid Production by the Gut Microbiota in a Gut Digestion/Fermentation Model |
Q50034270 | Effectiveness and Safety of a Probiotic-Mixture for the Treatment of Infantile Colic: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial with Fecal Real-Time PCR and NMR-Based Metabolomics Analysis |
Q46979950 | Effects of GI and content of indigestible carbohydrates of cereal-based evening meals on glucose tolerance at a subsequent standardised breakfast |
Q64940862 | Effects of Inulin Propionate Ester Incorporated into Palatable Food Products on Appetite and Resting Energy Expenditure: A Randomised Crossover Study. |
Q57074811 | Effects of Metabolites Derived From Gut Microbiota and Hosts on Pathogens |
Q63952143 | Effects of Weight-Loss Interventions on Short-Chain Fatty Acid Concentrations in Blood and Feces of Adults: A Systematic Review |
Q44247658 | Effects of a novel propionate-rich sourdough bread on appetite and food intake |
Q37694985 | Effects of butyric acid and arsenic on isolated pancreatic islets and liver mitochondria of male mouse |
Q51591139 | Effects of dietary propionate on hepatic glucose production, whole-body glucose utilization, carbohydrate and lipid metabolism in normal rats. |
Q51596352 | Effects of feeding restriction and meal pattern of a sugar beet-containing diet and control diet on nutrient digestibility, plasma lipid concentrations and postprandial triacylglycerol response in broiler chickens. |
Q90276857 | Effects of high-fat diet on liver injury after small bowel resection |
Q43119857 | Effects of oat bran, processed to different molecular weights of beta-glucan, on plasma lipids and caecal formation of SCFA in mice |
Q61443425 | Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males |
Q38857879 | Effects of propolis and gamma-cyclodextrin on intestinal neoplasia in normal weight and obese mice |
Q46606681 | Effects of proteoglycan on dextran sulfate sodium-induced experimental colitis in rats |
Q74212540 | Effects of short-chain fatty acids on human rectosigmoid mucosal colonocyte brush-border enzymes |
Q73627286 | Effects of sodium butyrate on growth, differentiation, and apoptosis in head and neck squamous carcinoma cell lines |
Q36374810 | Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults |
Q64261748 | Elevated Gut Microbiome-Derived Propionate Levels Are Associated With Reduced Sterile Lung Inflammation and Bacterial Immunity in Mice |
Q54649488 | Elevated propionate and butyrate in fecal ferments of hydrolysates generated by oxalic acid treatment of corn bran arabinoxylan. |
Q36373474 | Emergence of microbial diversity due to cross-feeding interactions in a spatial model of gut microbial metabolism. |
Q26772933 | Emergent Sources of Prebiotics: Seaweeds and Microalgae |
Q38795724 | Enterocyte glycosylation is responsive to changes in extracellular conditions: implications for membrane functions |
Q90325387 | Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases |
Q42119561 | Enterohemorrhagic Escherichia coli O157:H7 survival in an in vitro model of the human large intestine and interactions with probiotic yeasts and resident microbiota |
Q28078461 | Environmental factors in autoimmune diseases and their role in multiple sclerosis |
Q54331476 | Enzyme deactivation treatments did not decrease the beneficial role of oat food in intestinal microbiota and short-chain fatty acids: an in vivo study. |
Q40187559 | Epigenetic Metabolite Acetate Inhibits Class I/II Histone Deacetylases, Promotes Histone Acetylation, and Increases HIV-1 Integration in CD4+ T Cells |
Q34625951 | Epigenomic regulation of host-microbiota interactions |
Q31949036 | Erythritol: an interpretive summary of biochemical, metabolic, toxicological and clinical data |
Q39111708 | Escherichia coli pfs transcription: regulation and proposed roles in autoinducer-2 synthesis and purine excretion |
Q90281159 | Establishing a mucosal gut microbial community in vitro using an artificial simulator |
Q37676116 | Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans. |
Q34712475 | Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer |
Q35024999 | Exploring gut microbes in human health and disease: Pushing the envelope |
Q24669949 | Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system |
Q34431872 | Extracellular pH regulation in microdomains of colonic crypts: effects of short-chain fatty acids |
Q40777218 | Factors affecting fermentation reactions in the large bowel |
Q61797076 | Faecal bacterial and short-chain fatty acids signature in hypercholesterolemia |
Q51341604 | Fasting serum concentration of short-chain fatty acids in subjects with microscopic colitis and celiac disease: no difference compared with controls, but between genders. |
Q51651344 | Fecal Acetate Is Inversely Related to Acetate Absorption from the Human Rectum and Distal Colon |
Q39374069 | Fecal short chain fatty acids in South African Urban Africans and whites |
Q90381554 | Feed your gut with caution! |
Q89658945 | Feeding the Outer Bran Fraction of Rice Alters Hepatic Carbohydrate Metabolism in Rats |
Q48666754 | Fermentable carbohydrate alters hypothalamic neuronal activity and protects against the obesogenic environment. |
Q37352279 | Fermentation in the large intestine of single-stomached animals and its relationship to animal health |
Q38267839 | Fibre and enteral nutrition |
Q47367469 | Fish oil combined with SCFA synergistically prevent tissue accumulation of NEFA during weight loss in obese mice |
Q90574560 | Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition |
Q36747272 | Formate acts as a diffusible signal to induce Salmonella invasion |
Q30881746 | Formate-dependent growth and homoacetogenic fermentation by a bacterium from human feces: description of Bryantella formatexigens gen. nov., sp. nov |
Q37756247 | Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation |
Q43364082 | Free fatty acid receptor 3 activation suppresses neurogenic motility in rat proximal colon |
Q33460457 | Freeze-dried powdered yacon: effects of FOS on serum glucose, lipids and intestinal transit in the elderly |
Q38504501 | Fructo-oligosaccharide effects on serum cholesterol levels. An overview |
Q52882856 | Function and clinical implications of short-chain fatty acids in patients with mixed refractory constipation. |
Q33386016 | Functional characterization of a newly identified group B Streptococcus pullulanase eliciting antibodies able to prevent alpha-glucans degradation |
Q54113158 | Functional food science and gastrointestinal physiology and function. |
Q39217446 | Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location |
Q54404790 | G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. |
Q26766417 | GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative? |
Q36016849 | GPR41 gene expression is mediated by internal ribosome entry site (IRES)-dependent translation of bicistronic mRNA encoding GPR40 and GPR41 proteins. |
Q50143933 | GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. |
Q98209208 | GUT DYSBIOSIS AND AGE-RELATED NEUROLOGICAL DISEASES; AN INNOVATIVE APPROACH FOR THERAPEUTIC INTERVENTIONS |
Q36913757 | Gaining insight into microbial physiology in the large intestine: a special role for stable isotopes. |
Q88651319 | Gastrointestinal Disorders Associated with Primary Immunodeficiency Diseases |
Q43309790 | Gastrointestinal effects of modified guar gum and soy polysaccharide as part of an enteral formula diet |
Q28577016 | Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation |
Q33995875 | Global analysis of Escherichia coli gene expression during the acetate-induced acid tolerance response |
Q33994053 | Global regulatory mutations in csrA and rpoS cause severe central carbon stress in Escherichia coli in the presence of acetate |
Q27654484 | Group B Streptococcus Pullulanase Crystal Structures in the Context of a Novel Strategy for Vaccine Development |
Q67486850 | Guar, but not psyllium, increases breath methane and serum acetate concentrations in human subjects |
Q38919866 | Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion. |
Q52311437 | Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders. |
Q40594047 | Gut Microbial Metabolites Fuel Host Antibody Responses |
Q90192655 | Gut Microbial Protein Expression in Response to Dietary Patterns in a Controlled Feeding Study: A Metaproteomic Approach |
Q92106368 | Gut Microbiome and Modulation of CNS Function |
Q35765629 | Gut Microbiota Dysbiosis in Obesity-Linked Metabolic Diseases and Prebiotic Potential of Polyphenol-Rich Extracts |
Q60948654 | Gut Microbiota and Endothelial Dysfunction Markers in Obese Mexican Children and Adolescents |
Q28209082 | Gut flora in health and disease |
Q39013131 | Gut microbial metabolism defines host metabolism: an emerging perspective in obesity and allergic inflammation |
Q99616917 | Gut microbial metabolites as multi-kingdom intermediates |
Q63348106 | Gut microbial metabolites in obesity, NAFLD and T2DM |
Q57136925 | Gut microbiome in type 1 diabetes: A comprehensive review |
Q47339683 | Gut microbiome production of short-chain fatty acids and obesity in children |
Q46797438 | Gut microbiota and energy balance: role in obesity |
Q90460237 | Gut microbiota and pro/prebiotics in Alzheimer's disease |
Q35081904 | Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis |
Q91692304 | Gut microbiota metabolite regulation of host defenses at mucosal surfaces: implication in precision medicine |
Q91798966 | Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response |
Q36031926 | Gut microbiota, metabolites and host immunity |
Q35170535 | Gut microbiota-generated metabolites in animal health and disease |
Q89429091 | Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities |
Q47136595 | Gut-Brain Axis in Regulation of Blood Pressure. |
Q27021781 | Gut-central nervous system axis is a target for nutritional therapies |
Q26998106 | Gut/brain axis and the microbiota |
Q33254081 | H-NS controls metabolism and stress tolerance in Escherichia coli O157:H7 that influence mouse passage |
Q37956176 | HDACi: molecular mechanisms and therapeutic implications in the innate immune system |
Q34714843 | Harnessing the beneficial properties of adipogenic microbes for improving human health. |
Q21994485 | Health Benefits of Algal Polysaccharides in Human Nutrition |
Q55919832 | Health effects of resistant starch |
Q89749457 | Healthy Human Gastrointestinal Microbiome: Composition and Function After a Decade of Exploration |
Q35043961 | High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects |
Q35196152 | High-protein diet modifies colonic microbiota and luminal environment but not colonocyte metabolism in the rat model: the increased luminal bulk connection. |
Q57110714 | High-sensitivity detection of short-chain fatty acids in porcine ileal, cecal, portal and abdominal blood by gas chromatography-mass spectrometry |
Q34299299 | Higher-level production of volatile fatty acids in vitro by chicken gut microbiotas than by human gut microbiotas as determined by functional analyses |
Q49157474 | Highly viscous guar gum shifts dietary amino acids from metabolic use to fermentation substrate in domestic cats |
Q39864425 | Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice |
Q36351062 | Homeostatic Immunity and the Microbiota |
Q43083670 | Honeybee gut microbiota promotes host weight gain via bacterial metabolism and hormonal signaling |
Q57285502 | Host-associated niche metabolism controls enteric infection through fine-tuning the regulation of type 3 secretion |
Q28077145 | How gut microbes talk to organs: The role of endocrine and nervous routes |
Q35935903 | Human GPR42 is a transcribed multisite variant that exhibits copy number polymorphism and is functional when heterologously expressed. |
Q28278805 | Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonists |
Q41466082 | Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria |
Q96306955 | Human microbiome: an academic update on human body site specific surveillance and its possible role |
Q52729429 | Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice. |
Q40145966 | Human monocytes downregulate innate response receptors following exposure to the microbial metabolite n-butyrate. |
Q34248391 | Hydrogen sulfide as a gasotransmitter |
Q28294163 | Hydrogen sulphide: a bacterial toxin in ulcerative colitis? |
Q37890253 | Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis |
Q47152763 | Hypothesis: Induction of biomarkers for detection of colonic neoplasms |
Q92670011 | Hypothesis: Retinoblastoma protein inactivation mediates effects of histone deacetylase inhibitor-induced Wnt hyperactivation in colorectal cancer cells |
Q80015234 | Identification of intestinal bacteria responsible for fermentation of gum arabic in pig model |
Q61444266 | Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cells |
Q34377602 | Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism |
Q92088300 | Ileal and hindgut fermentation in the growing pig fed a human-type diet |
Q51688811 | Immobilization of infant fecal microbiota and utilization in an in vitro colonic fermentation model. |
Q26749134 | Immunity and Tolerance Induced by Intestinal Mucosal Dendritic Cells |
Q95840991 | Immunomodulation by Human Milk Oligosaccharides: The Potential Role in Prevention of Allergic Diseases |
Q57469429 | Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation |
Q61805982 | Impact of Gut Microbiota on Host Glycemic Control |
Q24622141 | Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa |
Q37448992 | Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo |
Q52325276 | Impacts of microbiome metabolites on immune regulation and autoimmunity. |
Q41900892 | In Salmonella enterica, 2-methylcitrate blocks gluconeogenesis |
Q36782192 | In Vitro Fermentation of caprine milk oligosaccharides by bifidobacteria isolated from breast-fed infants |
Q43226016 | In vitro contractile effects of short chain fatty acids in the rat terminal ileum. |
Q82975872 | In vitro fermented nuts exhibit chemopreventive effects in HT29 colon cancer cells |
Q39483706 | In vitro utilization of amylopectin and high-amylose maize (Amylomaize) starch granules by human colonic bacteria. |
Q50073361 | In vivo and in vitro analyses of single-amino acid variants of the Salmonella enterica phosphotransacetylase enzyme provide insights into the function of its N-terminal domain |
Q37034605 | Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods |
Q39563466 | Induction of acid resistance of Salmonella typhimurium by exposure to short-chain fatty acids |
Q35595280 | Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis |
Q36960218 | Influence of gut microbiota on subclinical inflammation and insulin resistance |
Q36076398 | Influence of pH, nutrient availability, and growth rate on amine production by Bacteroides fragilis and Clostridium perfringens |
Q36046450 | Inherent Variability of Growth Media Impacts the Ability of Salmonella Typhimurium to Interact with Host Cells |
Q35090110 | Interaction of Salmonella spp. with the Intestinal Microbiota |
Q40777224 | Interactions between nutrition and the intestinal microflora |
Q61811077 | Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats |
Q49685739 | Intestinal barrier and gut microbiota: Shaping our immune responses throughout life |
Q34941943 | Intestinal colonization: how key microbial players become established in this dynamic process: microbial metabolic activities and the interplay between the host and microbes |
Q43085163 | Intestinal fermentation modulates postprandial acylcarnitine profile and nitrogen metabolism in a true carnivore: the domestic cat ( Felis catus). |
Q37917290 | Intestinal health functions of colonic microbial metabolites: a review |
Q31146039 | Intestinal microbiota influence the early postnatal development of the enteric nervous system |
Q35170633 | Intraperitoneal administration of butyrate prevents the severity of acetic acid colitis in rats |
Q64080327 | Intraperitoneal delivery of acetate-encapsulated liposomal nanoparticles for neuroprotection of the penumbra in a rat model of ischemic stroke |
Q37607617 | Intravenous acetate elicits a greater free fatty acid rebound in normal than hyperinsulinaemic humans |
Q34038061 | Intrinsic mitochondrial membrane potential and associated tumor phenotype are independent of MUC1 over-expression |
Q51208893 | Investigations of bifidobacterial ecology and oligosaccharide metabolism in a three-stage compound continuous culture system. |
Q46402007 | Involvement of central immunity in uncomplicated diverticular disease |
Q44965759 | Iron-deficiency anaemia and physical performance in adolescent girls from different ethnic backgrounds |
Q58571502 | Is It Time to Use Probiotics to Prevent or Treat Obesity? |
Q39928317 | Is acetyl phosphate a global signal in Escherichia coli? |
Q34943068 | Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? |
Q41524099 | Is cytotoxicity a determinant of the different in vitro and in vivo effects of bioactives? |
Q61443789 | Isolation of wheat bran-colonizing and metabolizing species from the human fecal microbiota |
Q39016250 | Key Questions for Translation of FFA Receptors: From Pharmacology to Medicines |
Q50054542 | Killed Whole-Cell Oral Cholera Vaccine Induces CCL20 Secretion by Human Intestinal Epithelial Cells in the Presence of the Short-Chain Fatty Acid, Butyrate |
Q34408893 | Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis |
Q36818490 | LC-quadrupole/Orbitrap high-resolution mass spectrometry enables stable isotope-resolved simultaneous quantification and ¹³C-isotopic labeling of acyl-coenzyme A thioesters |
Q34695124 | Lactobacillus GG and tributyrin supplementation reduce antibiotic-induced intestinal injury |
Q91897418 | Lactobacillus frumenti mediates energy production via fatty acid β-oxidation in the liver of early-weaned piglets |
Q36846272 | Lactobacillus plantarum TWK10 Supplementation Improves Exercise Performance and Increases Muscle Mass in Mice. |
Q85899480 | Lactose malabsorption and colonic fermentations alter host metabolism in rats |
Q41494458 | Lactulose, disaccharides and colonic flora. Clinical consequences |
Q36037520 | Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance |
Q91026231 | Linking internal dosimetries of the propyl metabolic series in rats and humans using physiologically based pharmacokinetic (PBPK) modeling |
Q34581809 | Linking microbial community structure to function in representative simulated systems |
Q35616786 | LuxS and autoinducer-2: their contribution to quorum sensing and metabolism in bacteria. |
Q41660790 | MDG-1, a Potential Regulator of PPARα and PPARγ, Ameliorates Dyslipidemia in Mice |
Q51496307 | Macronutrient absorption characteristics in humans with short bowel syndrome and jejunocolonic anastomosis: starch is the most important carbohydrate substrate, although pectin supplementation may modestly enhance short chain fatty acid production a |
Q36585466 | Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells |
Q96304667 | Maize Bran Particle Size Governs the Community Composition and Metabolic Output of Human Gut Microbiota in in vitro Fermentations |
Q51299812 | Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content. |
Q92372498 | Maternal Fiber Dietary Intakes during Pregnancy and Infant Allergic Disease |
Q90633161 | Maternal carriage of Prevotella during pregnancy associates with protection against food allergy in the offspring |
Q40050902 | Maternal treatment with short-chain fatty acids modulates the intestinal microbiota and immunity and ameliorates type 1 diabetes in the offspring |
Q35762828 | Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells |
Q35880534 | Mechanism of Butyrate Stimulation of Triglyceride Storage and Adipokine Expression during Adipogenic Differentiation of Porcine Stromovascular Cells |
Q43919924 | Mechanism of n-butyrate uptake in the human proximal colonic basolateral membranes |
Q53676958 | Mechanisms and anticarcinogenic effects of diet-related apoptosis in the intestinal mucosa. |
Q38869770 | Mechanisms and consequences of intestinal dysbiosis. |
Q37897782 | Mechanisms and experimental and epidemiological evidence relating dietary fibre (non-starch polysaccharides) and starch to protection against large bowel cancer |
Q37589380 | Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention |
Q38935352 | Mechanisms of inflammation-driven bacterial dysbiosis in the gut. |
Q37255995 | Metabolic Interactions in the Gastrointestinal Tract (GIT): Host, Commensal, Probiotics, and Bacteriophage Influences |
Q37982824 | Metabolic and intestinal effects of short-chain fatty acids |
Q41466088 | Metabolic consequences of total colectomy |
Q34790948 | Metabolic control of regulatory T cell development and function |
Q64072898 | Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial |
Q38308759 | Metabolic regulation of histone post-translational modifications. |
Q34129385 | Metabolic tinkering by the gut microbiome: Implications for brain development and function |
Q26752828 | Metabolism meets immunity: The role of free fatty acid receptors in the immune system |
Q34757371 | Metabolism of propionic acid to a novel acyl-coenzyme A thioester by mammalian cell lines and platelets |
Q64982071 | Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease. |
Q39030292 | Metabolites: deciphering the molecular language between DCs and their environment. |
Q35914935 | Metabolomic applications to decipher gut microbial metabolic influence in health and disease |
Q30649847 | Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes. |
Q35911466 | Metastatic Melanoma Induced Metabolic Changes in C57BL/6J Mouse Stomach Measured by 1H NMR Spectroscopy. |
Q46530358 | Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome |
Q33609543 | Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX |
Q35825234 | Microbial composition and in vitro fermentation patterns of human milk oligosaccharides and prebiotics differ between formula-fed and sow-reared piglets |
Q35155187 | Microbial degradation of whole-grain complex carbohydrates and impact on short-chain fatty acids and health |
Q37968299 | Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. |
Q26751203 | Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions |
Q36814971 | Microbial metabolite butyrate facilitates M2 macrophage polarization and function |
Q28072517 | Microbial regulation of GLP-1 and L-cell biology |
Q38007408 | Microbial volatile compounds in health and disease conditions |
Q39363389 | Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification |
Q93247005 | Microbiome modulates intestinal homeostasis against inflammatory diseases |
Q39425413 | Microbiome, inflammation, epigenetic alterations, and mental diseases. |
Q53077901 | Microbiome-host systems interactions: protective effects of propionate upon the blood-brain barrier. |
Q38905774 | Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases |
Q33799023 | Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. |
Q40219642 | Microbiota-Derived Short-Chain Fatty Acids Modulate Expression of Campylobacter jejuni Determinants Required for Commensalism and Virulence |
Q58769405 | Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis |
Q46781242 | Micronized fibres affect in vitro fermentation under normal buffered and osmotic stress conditions using porcine inocula |
Q38107811 | Minireview: The effects of species ortholog and SNP variation on receptors for free fatty acids. |
Q37721268 | Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia? |
Q37240767 | Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds |
Q28072437 | Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate |
Q30363954 | Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines. |
Q53438921 | Modulation of p53 expression in cultured colonic adenoma cell lines by the naturally occurring lumenal factors butyrate and deoxycholate. |
Q37009028 | Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract |
Q51243743 | Molecular cloning of rat acss3 and characterization of mammalian propionyl-CoA synthetase in the liver mitochondrial matrix. |
Q37621335 | Molecular pathways: gene-environment interactions regulating dietary fiber induction of proliferation and apoptosis via butyrate for cancer prevention |
Q40355212 | Mouse GPR40 heterologously expressed in Xenopus oocytes is activated by short-, medium-, and long-chain fatty acids. |
Q90108789 | Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis |
Q34409826 | Mucosal enzyme activity for butyrate oxidation; no defect in patients with ulcerative colitis |
Q39538569 | Multiple factors independently regulate hilA and invasion gene expression in Salmonella enterica serovar typhimurium |
Q34515724 | Multiple regulation of peptide YY secretion in the digestive tract. |
Q90283100 | Natural Product Type III Secretion System Inhibitors |
Q35124765 | New insight into butyrate metabolism |
Q44266971 | Nicotinic induction of preproenkephalin and tyrosine hydroxylase gene expression in butyrate-differentiated rat PC12 cells: a model for adaptation to gut-derived environmental signals |
Q42041587 | Non-invasive method for delivery of tracer substances or small quantities of other materials to the colon |
Q71670931 | Non-ionic diffusion and carrier-mediated transport drive extracellullar pH regulation of mouse colonic crypts |
Q34993026 | Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro |
Q36505103 | Normal adaptation of Candida albicans to the murine gastrointestinal tract requires Efg1p-dependent regulation of metabolic and host defense genes |
Q43976228 | Novel mode of interference with nuclear factor of activated T-cells regulation in T-cells by the bacterial metabolite n-butyrate |
Q37463195 | Nutrient Transporter Expression in the Jejunum in Relation to Body Mass Index in Patients Undergoing Bariatric Surgery |
Q26864957 | Nutrient salvaging and metabolism by the intracellular pathogen Legionella pneumophila |
Q89462728 | Nutrition and gut health: the impact of specific dietary components - it's not just five-a-day |
Q41506343 | Nutrition and ulcerative colitis |
Q28070256 | Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review |
Q37095349 | Oat: unique among the cereals. |
Q52585849 | Obese Mice Losing Weight Due to trans-10,cis-12 Conjugated Linoleic Acid Supplementation or Food Restriction Harbor Distinct Gut Microbiota. |
Q35642246 | Obesity and the gastrointestinal microbiota: a review of associations and mechanisms |
Q46593547 | Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. |
Q57419329 | Odd-Numbered Medium-Chain Triglycerides (Trinonanoin) in Total Parenteral Nutrition: Effects on Parameters of Fat Metabolism in Rabbits |
Q24316710 | Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation |
Q35701455 | Overview of the gastrointestinal microbiota |
Q33259655 | Oxygen limitation modulates pH regulation of catabolism and hydrogenases, multidrug transporters, and envelope composition in Escherichia coli K-12. |
Q93366073 | Oxygen-dependent regulation of SPI1 type three secretion system by small RNAs in Salmonella enterica serovar Typhimurium |
Q26771948 | Part 1: The Human Gut Microbiome in Health and Disease |
Q35049771 | Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity |
Q49817851 | Pathophysiology of Enteral Feeding Diarrhea: The Intestinal Responses to Enteral Feeding Rather Than Any Role of FODMAPs |
Q57222222 | Pathophysiology of diarrhoea and the role of fibre in enteral nutrition |
Q35113085 | Perspectives on the use of organic acids and short chain fatty acids as antimicrobials |
Q34327461 | Pharmacological and genetic modulation of Wnt-targeted Cre-Lox-mediated gene expression in colorectal cancer cells |
Q35530168 | Phenotypic diversity caused by differential RpoS activity among environmental Escherichia coli isolates |
Q43522975 | Phylogenetic group-associated differences in regulation of the common colonization factor Mat fimbria in Escherichia coli |
Q33986987 | Phylogenetic relationships of butyrate-producing bacteria from the human gut. |
Q36066325 | Physiologic hypoxia and oxygen homeostasis in the healthy intestine. A Review in the Theme: Cellular Responses to Hypoxia. |
Q37076280 | Physiological TLR5 expression in the intestine is regulated by differential DNA binding of Sp1/Sp3 through simultaneous Sp1 dephosphorylation and Sp3 phosphorylation by two different PKC isoforms |
Q35956589 | Physiological and nutritional factors affecting synthesis of extracellular metalloproteases by Clostridium bifermentans NCTC 2914 |
Q42604420 | Physiological modeling and assessments of regional drug bioavailability of danoprevir to determine whether a controlled release formulation is feasible |
Q34970905 | Plasmacytoid dendritic cells are crucial in Bifidobacterium adolescentis-mediated inhibition of Yersinia enterocolitica infection |
Q35558072 | Polarized Na+/H+ exchange function is pliable in response to transepithelial gradients of propionate |
Q33459557 | Polymorphism and selection of rpoS in pathogenic Escherichia coli |
Q34396164 | Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery |
Q42722927 | Possible errors in the analysis of lactic acid and volatile fatty acids in the gastrointestinal tracts of pigs and chickens |
Q28372218 | Possible mechanisms through which dietary pectin influences fibrin network architecture in hypercholesterolaemic subjects |
Q43087965 | Potassium glutamate as a transcriptional inhibitor during bacterial osmoregulation |
Q51680025 | Potential fat-lowering and prebiotic effects of enzymatically treated okara in high-cholesterol-fed Wistar rats. |
Q34529060 | Prebiotics to fight diseases: reality or fiction? |
Q37778794 | Prediction of in vivo short-chain fatty acid production in hindgut fermenting mammals: problems and pitfalls |
Q93155875 | Predictors of Obesity among Gut Microbiota Biomarkers in African American Men with and without Diabetes |
Q39969694 | Preliminary X-ray crystallographic analysis of 2-methylcitrate synthase from Salmonella typhimurium |
Q39643695 | Preliminary X-ray crystallographic studies on acetate kinase (AckA) from Salmonella typhimurium in two crystal forms. |
Q92895944 | Prenatal hypoxia inhibited propionate-evoked BK channels of mesenteric artery smooth muscle cells in offspring |
Q37610379 | Priming nanoparticle-guided diagnostics and therapeutics towards human organs-on-chips microphysiological system |
Q36885139 | Probiotics and prebiotics in infant nutrition |
Q34124324 | Prokaryotic and eukaryotic diversity of the human gut. |
Q91638657 | Propionate Ameliorates Staphylococcus aureus Skin Infection by Attenuating Bacterial Growth |
Q98177615 | Propionate Induces Virulent Properties of Crohn's Disease-Associated Escherichia coli |
Q37869183 | Propionate as a health-promoting microbial metabolite in the human gut. |
Q43875686 | Propionate-induced relaxation in rat mesenteric arteries: a role for endothelium-derived hyperpolarising factor |
Q89787733 | Propionic Acid Promotes the Virulent Phenotype of Crohn's Disease-Associated Adherent-Invasive Escherichia coli |
Q41189607 | Propionic acid and butyric acid inhibit lipolysis and de novo lipogenesis and increase insulin-stimulated glucose uptake in primary rat adipocytes |
Q86493364 | Propionic and butyric acids, formed in the caecum of rats fed highly fermentable dietary fibre, are reflected in portal and aortic serum |
Q34984246 | Propolis augments apoptosis induced by butyrate via targeting cell survival pathways |
Q36922396 | Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats |
Q47450328 | Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer's disease-type beta-amyloid neuropathological mechanisms |
Q92702462 | Quantification of Fecal Short Chain Fatty Acids by Liquid Chromatography Tandem Mass Spectrometry-Investigation of Pre-Analytic Stability |
Q36329760 | Quantification of in Vivo Colonic Short Chain Fatty Acid Production from Inulin. |
Q64093718 | RNA Sequencing Analysis of Molecular Basis of Sodium Butyrate-Induced Growth Inhibition on Colorectal Cancer Cell Lines |
Q37261858 | Randomised clinical study: inulin short-chain fatty acid esters for targeted delivery of short-chain fatty acids to the human colon. |
Q34245355 | Randomised clinical trial: efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation--a double-blind, controlled, crossover study |
Q28206230 | Randomized controlled crossover study of the effect of a highly β-glucan–enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men |
Q39398757 | Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria |
Q38575337 | Recovery of inulin from Jerusalem artichoke (Helianthus tuberosus L.) in the small intestine of man. |
Q40905859 | Redirection of Epithelial Immune Responses by Short-Chain Fatty Acids through Inhibition of Histone Deacetylases |
Q35426826 | Reevaluating the hype: four bacterial metabolites under scrutiny |
Q88656338 | Regional control of regulatory immune cells in the intestine |
Q38892445 | Regional differences in nutrient-induced secretion of gut serotonin. |
Q52728485 | Regulation of Ion Transport in the Intestine by Free Fatty Acid Receptor 2 and 3: Possible Involvement of the Diffuse Chemosensory System. |
Q40629259 | Regulation of butyrate uptake in Caco-2 cells by phorbol 12-myristate 13-acetate |
Q41542179 | Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2. |
Q91655095 | Regulation of colonic epithelial butyrate transport: Focus on colorectal cancer |
Q41162511 | Regulation of human colonic cell line proliferation and phenotype by sodium butyrate |
Q37976701 | Regulation of inflammation by short chain fatty acids |
Q35124759 | Regulation of short-chain fatty acid production |
Q98892417 | Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease |
Q46309765 | Regulation of transcription by acetate in Escherichia coli: in vivo and in vitro comparisons |
Q49861299 | Regulatory T Cell Metabolism in the Hepatic Microenvironment |
Q50146955 | Regulatory effects of bifidobacteria on the growth of other colonic bacteria |
Q46244021 | Removal of the cecum affects intestinal fermentation, enteric bacterial community structure, and acute colitis in mice. |
Q39743784 | Repression of Escherichia coli PhoP-PhoQ signaling by acetate reveals a regulatory role for acetyl coenzyme A. |
Q52880767 | Reprogramming of hepatic fat accumulation and 'browning' of adipose tissue by the short-chain fatty acid acetate. |
Q55980977 | Resistant Starch: Physiological Roles and Food Applications |
Q35910146 | Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients? |
Q35019426 | Resistant starch induces catabolic but suppresses immune and cell division pathways and changes the microbiome in the proximal colon of male pigs |
Q91835972 | Resistant starch supplementation increases crypt cell proliferative state in the rectal mucosa of older healthy participants |
Q90507291 | Respiratory microbiome and epithelial interactions shape immunity in the lungs |
Q28251129 | Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon |
Q38623020 | Review article: insights into colonic protein fermentation, its modulation and potential health implications |
Q38688196 | Review of mechanisms of deoxynivalenol-induced anorexia: The role of gut microbiota |
Q31131918 | Role of Gut Microbiota and Short Chain Fatty Acids in Modulating Energy Harvest and Fat Partitioning in Youth. |
Q55527145 | Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders. |
Q89442826 | Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology |
Q58705680 | Role of Short Chain Fatty Acids in Controlling T and Immunopathology During Mucosal Infection |
Q34067921 | Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies |
Q34450176 | Role of intestinal bacteria in nutrient metabolism |
Q38731353 | Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing |
Q33752553 | Role of the microbiota in immunity and inflammation |
Q90641458 | Role of whole grains versus fruits and vegetables in reducing subclinical inflammation and promoting gastrointestinal health in individuals affected by overweight and obesity: a randomized controlled trial |
Q36599366 | Rye bread consumption in early life and reduced risk of advanced prostate cancer |
Q90831423 | SCFA: mechanisms and functional importance in the gut |
Q28743600 | SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor |
Q48293164 | SCFAs strongly stimulate PYY production in human enteroendocrine cells. |
Q41826299 | Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects |
Q26999425 | Salmonella pathogenicity and host adaptation in chicken-associated serovars |
Q43087450 | Salt and water absorption in the human colon: a modern appraisal |
Q35969570 | Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease |
Q39808932 | Schlafen-3: a novel regulator of intestinal differentiation |
Q64107796 | Secondary Bile Acids and Short Chain Fatty Acids in the Colon: A Focus on Colonic Microbiome, Cell Proliferation, Inflammation, and Cancer |
Q35222490 | Selection of optimal lipid sources in enteral and parenteral nutrition |
Q36209781 | Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids |
Q34940785 | Sequencing the human microbiome in health and disease. |
Q68071058 | Serum levels of short-chain fatty acids in cirrhosis and hepatic coma |
Q34377275 | Sex differences in colonic function: a randomised trial. |
Q39414117 | Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk |
Q33489940 | Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin. |
Q38756693 | Short Chain Fatty Acids (SCFA) Reprogram Gene Expression in Human Malignant Epithelial and Lymphoid Cells |
Q64107231 | Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases |
Q92050243 | Short Chain Fatty Acids Commonly Produced by Gut Microbiota Influence Salmonella enterica Motility, Biofilm Formation, and Gene Expression |
Q49205960 | Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance |
Q38059306 | Short chain fatty acids and their receptors: new metabolic targets |
Q34289566 | Short chain fatty acids dilate isolated human colonic resistance arteries |
Q50088491 | Short chain fatty acids influence virulence properties of Salmonella enterica serovar Typhimurium. |
Q42091545 | Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts |
Q42766173 | Short- and medium-chain fatty acids in energy metabolism: the cellular perspective |
Q64992782 | Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage. |
Q64927604 | Short-Chain Fatty Acids Alter Metabolic and Virulence Attributes of Borrelia burgdorferi. |
Q49631434 | Short-Chain Fatty Acids Differentially Affect Intracellular Lipolysis in a Human White Adipocyte Model |
Q57594184 | Short-Chain Fatty Acids Regulate Cytokines and Th17/Treg Cells in Human Peripheral Blood Mononuclear Cellsin vitro |
Q38830276 | Short-Chain Fatty Acids Regulate Secretion of IL-8 from Human Intestinal Epithelial Cell Lines in vitro |
Q64097047 | Short-chain Fatty Acids Inhibit Staphylococcal Lipoprotein-induced Nitric Oxide Production in Murine Macrophages |
Q27937522 | Short-chain fatty acid activation by acyl-coenzyme A synthetases requires SIR2 protein function in Salmonella enterica and Saccharomyces cerevisiae |
Q43865093 | Short-chain fatty acid and organic acid concentrations in feces of 10 human volunteers and their correlation with anaerobe cultural over a 15-month period |
Q73828155 | Short-chain fatty acid enemas stimulate plasminogen activator inhibitor-1 after abdominal aortic graft surgery: a double-blinded, placebo-controlled study |
Q46188862 | Short-chain fatty acid sensing in rat duodenum. |
Q50123614 | Short-chain fatty acids affect cell-association and invasion of HEp-2 cells by Salmonella typhimurium |
Q93008951 | Short-chain fatty acids and regulation of pancreatic endocrine secretion in mice |
Q97643860 | Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function |
Q51606838 | Short-chain fatty acids do not alter jejunal motility in man. |
Q35741824 | Short-chain fatty acids in control of body weight and insulin sensitivity |
Q34681642 | Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway |
Q45195993 | Short-chain fatty acids induce colonic mucosal injury in rats with various postnatal ages |
Q73009255 | Short-chain fatty acids induce cytoskeletal and extracellular protein modifications associated with modulation of proliferation on primary culture of rat intestinal smooth muscle cells |
Q57594198 | Short-chain fatty acids produced by synbiotic mixtures in skim milk differentially regulate proliferation and cytokine production in peripheral blood mononuclear cells |
Q30538765 | Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ |
Q44391164 | Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats |
Q24304955 | Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41 |
Q39336547 | Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB pathway in RAW264.7 cells |
Q77485113 | Short-chain fatty acids: good for the colon, good also for the urothelium? |
Q50120935 | Short-chain volatile fatty acids modulate the expression of the hilA and invF genes of Salmonella typhimurium |
Q37983582 | Short-term tests and long-term prospects for colon cancer prevention |
Q42097668 | Significance of microflora in proteolysis in the colon |
Q91330090 | Site-specific acylation of a bacterial virulence regulator attenuates infection |
Q90427162 | Social Stress Affects Colonic Inflammation, the Gut Microbiome, and Short-chain Fatty Acid Levels and Receptors |
Q57054506 | Sodium Butyrate Enhances Intestinal Riboflavin Uptake via Induction of Expression of Riboflavin Transporter-3 (RFVT3) |
Q35897745 | Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells: Implications for Apoptosis |
Q43773479 | Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells |
Q90483876 | Sodium, hypertension, and the gut: does the gut microbiota go salty? |
Q74741175 | Soluble and insoluble fiber influences on cancer development |
Q92375514 | Soluble fibre supplementation with and without a probiotic in adults with asthma: A 7-day randomised, double blind, three way cross-over trial |
Q35019290 | Spatial heterogeneity and co-occurrence patterns of human mucosal-associated intestinal microbiota |
Q35094399 | Stable differences in intrinsic mitochondrial membrane potential of tumor cell subpopulations reflect phenotypic heterogeneity |
Q44630760 | Starch fermentation by faecal bacteria of infants, toddlers and adults: importance for energy salvage |
Q35978415 | Starch intake and colorectal cancer risk: an international comparison |
Q27701748 | Structures of substrate- and nucleotide-bound propionate kinase from Salmonella typhimurium: substrate specificity and phosphate-transfer mechanism |
Q43619491 | Studies of propionate toxicity in Salmonella enterica identify 2-methylcitrate as a potent inhibitor of cell growth |
Q42927500 | Studies on mixed populations of human intestinal bacteria grown in single-stage and multistage continuous culture systems |
Q38350816 | Substrates available for colonic fermentation from oat, barley and wheat bread diets. A study in ileostomy subjects |
Q52339897 | Succinate-acetate permease from Citrobacter koseri is an anion channel that unidirectionally translocates acetate. |
Q33673855 | Sulfation of colonic mucins by N-acetylglucosamine 6-O-sulfotransferase-2 and its protective function in experimental colitis in mice |
Q77349083 | Sulfur metabolism in ulcerative colitis: investigation of detoxification enzymes in peripheral blood |
Q41544554 | Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases |
Q40753009 | Suppression of promoter-dependent transcriptional activity of inducible nitric oxide synthase by sodium butyrate in colon cancer cells. |
Q64283346 | Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice |
Q91975000 | Synthetic dietary inulin, Fuji FF, delays development of diet-induced obesity by improving gut microbiota profiles and increasing short-chain fatty acid production |
Q64249465 | Systematic Review of Gut Microbiota and Major Depression |
Q36927947 | Systemic Concentrations of Short Chain Fatty Acids Are Elevated in Salmonellosis and Exacerbation of Familial Mediterranean Fever |
Q99555096 | Systemic Immunometabolism: Challenges and Opportunities |
Q94483861 | Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer |
Q49571439 | Taking a prebiotic approach to early immunomodulation for allergy prevention |
Q41928977 | Targeting Innate Immunity for Type 1 Diabetes Prevention |
Q38548027 | Targeting fatty acid metabolism to improve glucose metabolism. |
Q48047320 | The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis |
Q73384533 | The British Society of Gastroenterology Diamond Jubilee. March 1997 |
Q98465508 | The Butyrogenic and Lactic Bacteria of the Gut Microbiota Determine the Outcome of Allogenic Hematopoietic Cell Transplant |
Q35913803 | The Circadian Clock Mutation Promotes Intestinal Dysbiosis. |
Q64094728 | The Combination of 2'-Fucosyllactose with Short-Chain Galacto-Oligosaccharides and Long-Chain Fructo-Oligosaccharides that Enhance Influenza Vaccine Responses Is Associated with Mucosal Immune Regulation in Mice |
Q55715216 | The Expensive-Tissue Hypothesis in Vertebrates: Gut Microbiota Effect, a Review. |
Q92353620 | The Gut Microbiota Affects Host Pathophysiology as an Endocrine Organ: A Focus on Cardiovascular Disease |
Q89943833 | The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases |
Q92047923 | The Gut Microbiota in Cardiovascular Disease and Arterial Thrombosis |
Q55208662 | The Impact of Carnitine on Dietary Fiber and Gut Bacteria Metabolism and Their Mutual Interaction in Monogastrics. |
Q64108732 | The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release |
Q90040737 | The Intestine of Drosophila melanogaster: An Emerging Versatile Model System to Study Intestinal Epithelial Homeostasis and Host-Microbial Interactions in Humans |
Q37731038 | The Maternal Diet, Gut Bacteria, and Bacterial Metabolites during Pregnancy Influence Offspring Asthma |
Q90229288 | The Microbial Pecking Order: Utilization of Intestinal Microbiota for Poultry Health |
Q91635479 | The Response of the Gut Microbiota to Dietary Changes in the First Two Years of Life |
Q49630753 | The Role of Lipid Metabolism in T Lymphocyte Differentiation and Survival |
Q36812245 | The Role of Lipids in Nutrition during the First Months of Life |
Q89820476 | The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication |
Q92151798 | The Role of the Gut Microbiota in Lipid and Lipoprotein Metabolism |
Q28276657 | The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease |
Q92703624 | The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity |
Q47117173 | The Short-Chain Fatty Acid Propionate Inhibits Adipogenic Differentiation of Human Chorion-Derived Mesenchymal Stem Cells Through the Free Fatty Acid Receptor 2. |
Q36442568 | The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation |
Q33755202 | The acetate switch |
Q91160354 | The association between dietary fibre deficiency and high-income lifestyle-associated diseases: Burkitt's hypothesis revisited |
Q34610917 | The bifidogenic effect of inulin and oligofructose and its consequences for gut health |
Q41743838 | The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease |
Q35358530 | The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis |
Q37455596 | The control and consequences of bacterial fermentation in the human colon |
Q93061885 | The distal intestinal microbiome of hybrids of Hainan black goats and Saanen goats |
Q42719856 | The effect of high and low dietary crude protein and inulin supplementation on nutrient digestibility, nitrogen excretion, intestinal microflora and manure ammonia emissions from finisher pigs |
Q45891201 | The effect of lactulose, pectin, arabinogalactan and cellulose on the production of organic acids and metabolism of ammonia by intestinal bacteria in a faecal incubation system |
Q35833770 | The effect of short-chain fatty acids on human monocyte-derived dendritic cells |
Q35206226 | The effects of the microbiota on the host immune system. |
Q39313008 | The enhancement of phase 2 enzyme activities by sodium butyrate in normal intestinal epithelial cells is associated with Nrf2 and p53. |
Q21131158 | The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome |
Q92958030 | The gut microbiota and its interactions with cardiovascular disease |
Q58740602 | The gut microbiota promotes hepatic fatty acid desaturation and elongation in mice |
Q36636799 | The intestinal fatty acid propionate inhibits Salmonella invasion through the post-translational control of HilD |
Q36113718 | The metabolic fate of acetate in cancer |
Q33809275 | The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer |
Q29616351 | The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis |
Q91580929 | The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay? |
Q48226415 | The microbiota metabolite indole inhibits Salmonella virulence: Involvement of the PhoPQ two-component system |
Q38934122 | The nutrient-sensing repertoires of mouse enterochromaffin cells differ between duodenum and colon. |
Q39402852 | The nutrition-gut microbiome-physiology axis and allergic diseases. |
Q44923280 | The peristaltic reflex induced by short-chain fatty acids is mediated by sequential release of 5-HT and neuronal CGRP but not BDNF. |
Q90364489 | The propionic acid and butyric acid in serum but not in feces are increased in patients with diarrhea-predominant irritable bowel syndrome |
Q37228503 | The protective potency of probiotic bacteria and their microbial products against enteric infections-review |
Q28080686 | The role of Fatty Acid oxidation in the metabolic reprograming of activated t-cells |
Q38219120 | The role of alginates in regulation of food intake and glycemia: a gastroenterological perspective. |
Q41326181 | The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis? |
Q34437865 | The role of commensal bacteria in the regulation of sensitization to food allergens |
Q35631071 | The role of short chain fatty acids in appetite regulation and energy homeostasis. |
Q92256387 | The role of short-chain fatty acids in microbiota-gut-brain communication |
Q34355154 | The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism |
Q41131866 | The scientific rationale and clinical application of short-chain fatty acids and medium-chain triacylglycerols |
Q39503464 | The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein |
Q28256143 | The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes |
Q91634680 | The small chain fatty acid butyrate antagonizes the TCR-stimulation-induced metabolic shift in murine epidermal gamma delta T cells |
Q38121495 | The therapeutic potential of GPR43: a novel role in modulating metabolic health. |
Q27645809 | The three-dimensional crystal structure of the PrpF protein ofShewanella oneidensiscomplexed withtrans-aconitate: Insights into its biological function |
Q52632503 | The use of nutritional supplements to induce ketosis and reduce symptoms associated with keto-induction: a narrative review |
Q78600128 | Thermogenesis associated with fermentable carbohydrate in humans, validity of indirect calorimetry, and implications of dietary thermogenesis for energy requirements, food energy and body weight |
Q92723849 | Three Structural Features of Functional Food Components and Herbal Medicine with Amyloid β42 Anti-Aggregation Properties |
Q51574714 | Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. |
Q44764010 | Too much short chain fatty acids cause neonatal necrotizing enterocolitis |
Q36033156 | Transcriptomic Analysis of the Adaptation of Listeria monocytogenes to Growth on Vacuum-Packed Cold Smoked Salmon |
Q34468976 | Transcriptomic profiling of Yersinia pseudotuberculosis reveals reprogramming of the Crp regulon by temperature and uncovers Crp as a master regulator of small RNAs |
Q85246550 | Transepithelial transport and intraepithelial metabolism of short-chain fatty acids (SCFA) in the porcine proximal colon are influenced by SCFA concentration and luminal pH |
Q27967673 | Tumor-suppressive functions of leucine zipper transcription factor-like 1. |
Q87917259 | Type 3 regulatory T cells at the interface of symbiosis |
Q39381331 | Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System |
Q94559451 | Understanding the interplay between food structure, intestinal bacterial fermentation and appetite control |
Q34117156 | Urease of enterohemorrhagic Escherichia coli: evidence for regulation by fur and a trans-acting factor |
Q39927332 | Use of a three-stage continuous culture system to study the effect of mucin on dissimilatory sulfate reduction and methanogenesis by mixed populations of human gut bacteria. |
Q50267268 | Utilization of multiple substrates by butyrate kinase from Listeria monocytogenes |
Q36597901 | Vancomycin treatment and butyrate supplementation modulate gut microbe composition and severity of neointimal hyperplasia after arterial injury |
Q36064244 | Variable responses of human microbiomes to dietary supplementation with resistant starch |
Q58102229 | Ventilator-induced lung injury is aggravated by antibiotic mediated microbiota depletion in mice |
Q38841654 | Vinegar as a functional ingredient to improve postprandial glycemic control-human intervention findings and molecular mechanisms |
Q72666808 | Why fibre is good for you |
Q38219098 | Xylitol: a review on bioproduction, application, health benefits, and related safety issues |
Q41077299 | ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC. |
Q89799717 | [Gut-heart axis : How gut bacteria influence cardiovascular diseases] |
Q73985170 | n-butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids |
Q67848553 | n-butyrate reduces the expression of beta-galactoside alpha 2,6-sialyltransferase in Hep G2 cells |
Q41967874 | p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells |
Q33554062 | pH regulates genes for flagellar motility, catabolism, and oxidative stress in Escherichia coli K-12. |
Search more.